Filing Details
- Accession Number:
- 0001209191-15-045582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-21 18:28:58
- Reporting Period:
- 2015-05-19
- Filing Date:
- 2015-05-21
- Accepted Time:
- 2015-05-21 18:28:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442675 | Daniel Scott Cormack | 400-1001 W. Broadway Vancouver A1 V6H 4B1 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-19 | 15,624 | $0.00 | 114,681 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-20 | 7,543 | $1.88 | 107,138 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2015-05-19 | 4,687 | $0.00 | 4,687 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2015-05-19 | 4,687 | $0.00 | 4,687 | $0.00 |
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2015-05-19 | 6,250 | $0.00 | 6,250 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2015-05-19 | 75,000 | $0.00 | 75,000 | $1.86 |
| Common | Restricted Stock Unit (RSU) | Acquisiton | 2015-05-19 | 37,500 | $0.00 | 37,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,687 | 2016-01-31 | No | 4 | M | Direct | |
| 9,375 | 2017-01-31 | No | 4 | M | Direct | |
| 18,750 | 2018-04-13 | No | 4 | M | Direct | |
| 75,000 | 2025-05-19 | No | 4 | A | Direct | |
| 37,500 | 2019-06-18 | No | 4 | A | Direct |
Footnotes
- Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
- Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest on March 12, 2013 and then annually on the later of: (i) each anniversary of January 1, 2012; and (ii) the first day thereafter during which the issuer's trading window is open.
- Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open.
- Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.
- The options vest in monthly installments over 48 months commencing one month from January 1, 2015.
- Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open.
Billionaire Hedge Funds
